Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

por Rubbert-Roth, Andrea, Finckh, Axel
Publicado 2009

Pausing drugs and spacing vaccines: an open question – Authors' reply

por Rubbert-Roth, Andrea, Schmiedeberg, Kristin, von Kempis, Johannes
Publicado 2021

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases

por Finckh, Axel, Ciurea, Adrian, Raptis, Catherine E, Rubbert-Roth, Andrea
Publicado 2023

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis

por Haller, Christoph, Cozzio, Antonio, von Kempis, Johannes, Rubbert-Roth, Andrea
Publicado 2021

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

por Rubbert-Roth, Andrea, Vuilleumier, Nicolas, Ludewig, Burkhard, Schmiedeberg, Kristin, Haller, Christoph, von Kempis, Johannes
Publicado 2021

Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

por Schultz, Olaf, Oberhauser, Frank, Saech, Jasemine, Rubbert-Roth, Andrea, Hahn, Moritz, Krone, Wilhelm, Laudes, Matthias
Publicado 2010

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?

por Vuilleumier, Nicolas, Pagano, Sabrina, Ludewig, Burkhard, Schmiedeberg, Kristin, Haller, Christoph, von Kempis, Johannes, Rubbert‐Roth, Andrea
Publicado 2021

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses

por Schmiedeberg, Kristin, Vuilleumier, Nicolas, Pagano, Sabrina, Albrich, Werner C, Ludewig, Burkhard, Kempis, Johannes von, Rubbert-Roth, Andrea
Publicado 2022

Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis

por Rubbert-Roth, Andrea, Aletaha, Daniel, Devenport, Jenny, Sidiropoulos, Paris N, Luder, Yves, Edwardes, Michael D, Jacobs, Johannes W G
Publicado 2020

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

por Rubbert-Roth, Andrea, Tak, Paul P., Zerbini, Cristiano, Tremblay, Jean-Luc, Carreño, Luis, Armstrong, Gillian, Collinson, Neil, Shaw, Tim M.
Publicado 2010

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

por Rubbert-Roth, Andrea, Sebba, Anthony, Brockwell, Laura, Kelman, Ariella, Porter-Brown, Benjamin, Pulley, Jennifer, Napalkov, Pavel, van Vollenhoven, Ronald F
Publicado 2016

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

por Alten, Rieke, Burkhardt, Harald, Feist, Eugen, Krüger, Klaus, Rech, Juergen, Rubbert-Roth, Andrea, Voll, Reinhard E., Elbez, Yedid, Rauch, Christiane
Publicado 2018

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials...

por Rubbert-Roth, Andrea, Furst, Daniel E., Fiore, Stefano, Praestgaard, Amy, Bykerk, Vivian, Bingham, Clifton O., Charles-Schoeman, Christina, Burmester, Gerd
Publicado 2022

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

por Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Kelman, Ariella, Dimonaco, Sophie, Mitchell, Nina
Publicado 2016

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results...

por Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Blanco, Ricardo, Kadva, Alysha, Dimonaco, Sophie
Publicado 2017

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective p...

por Emery, Paul, Mease, Philip J., Rubbert-Roth, Andrea, Curtis, Jeffrey R., Müller-Ladner, Ulf, Gaylis, Norman B., Williams, Sarah, Reynard, Mark, Tyrrell, Helen
Publicado 2011

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

por Tak, Paul P, Rigby, William, Rubbert-Roth, Andrea, Peterfy, Charles, van Vollenhoven, Ronald F, Stohl, William, Healy, Emma, Hessey, Eva, Reynard, Mark, Shaw, Tim
Publicado 2011

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts

por Mueller, Ruediger B., Hasler, Caroline, Popp, Florian, Mattow, Frederik, Durmisi, Mirsada, Souza, Alexander, Hasler, Paul, Rubbert-Roth, Andrea, Schulze-Koops, Hendrik, von Kempis, Johannes
Publicado 2019

Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies

por Taylor, Peter C., Chen, Yun-Fei, Pope, Janet, Weinblatt, Michael, Mysler, Eduardo, Rubbert-Roth, Andrea, Jia, Bochao, Sun, Luna, Liu, Yushi, Holzkämper, Thorsten, Tanaka, Yoshiya
Publicado 2023

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

por Moots, Robert J., Sebba, Anthony, Rigby, William, Ostor, Andrew, Porter-Brown, Benjamin, Donaldson, Francis, Dimonaco, Sophie, Rubbert-Roth, Andrea, van Vollenhoven, Ronald, Genovese, Mark C.
Publicado 2017